Usted buscó: responsivi (Maltés - Inglés)

li ma jkunux adegwatament responsivi għal jew intolleranti mill- kuri konvenzjonali bħala ma huma il - kortikosterojdi topikali.
not adequately responsive to or are intolerant of conventional therapies such as topical corticosteroids.

total ta ’ 130 pazjent ġew rekrutati li kienu jikkonsistu minn 67 pazjent reżistenti għat- tip a u 63 responsivi għal tip a.
a total of 130 subjects were enrolled, comprising 67 type a resistant and 63 type a responsive.

il-kura ta’ dermatite atopika moderata jew severa fl-adulti li ma jkunux adegwatament responsivi għal jew intolleranti għal terapiji konvenzjonali bħalma huma l-kortikosterojdi topikali.
treatment of moderate to severe atopic dermatitis in adults who are not adequately responsive to or are intolerant of conventional therapies such as topical corticosteroids.

l-ingwent protopic 0.03% jintuża biex jikkura dermatite atopika moderata għal severa (ekżema) fil- kbar li ma jkunux adegwatament responsivi għal jew intolleranti mill-kuri konvenzjonali bħala ma huma il-kortikosterojdi topikali u fit-tfal (ta’ sentejn jew akbar) li kura konvenzjonali bħalama huma il-kortikosterojdi topikali ma ħadmitx fuqhom biżżejjed.
protopic 0.03% ointment is used to treat moderate to severe atopic dermatitis (eczema) in adults who are not adequately responsive to or are intolerant of conventional therapies such as topical corticosteroids and in children (2 years of age and older) who failed to respond adequately to conventional therapies such as topical corticosteroids.